| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/25/2004 | EP1448199A1 Benzimidazoles useful as protein kinase inhibitors |
| 08/25/2004 | EP1448198A1 Nicotin-or isonicotin benzothiazole derivatives |
| 08/25/2004 | EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 08/25/2004 | EP1448192A2 Novel methods of treating local fungal and bacterial infections |
| 08/25/2004 | EP1448184A1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease |
| 08/25/2004 | EP1448180A1 Para-amino benzoic acids as integrin antagonists |
| 08/25/2004 | EP1448152A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1347963B1 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
| 08/25/2004 | EP1343764B1 Urea and urethane derivatives as integrin inhibitors |
| 08/25/2004 | EP1212067A4 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 08/25/2004 | EP1169337B1 Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction |
| 08/25/2004 | EP1149069B1 Phenylglycine derivatives |
| 08/25/2004 | EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 08/25/2004 | EP1083903B1 Bridged indenopyrrolocarbazoles |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP1025094B1 Substituted indan derivatives |
| 08/25/2004 | EP0883616B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | CN1524092A Concatameric immunoadhesion |
| 08/25/2004 | CN1524081A Pyrimidine derivatives for inhibition of cell proliferation |
| 08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 08/25/2004 | CN1524079A Novel sulfamides and their use as endothelin receptor antagonists |
| 08/25/2004 | CN1524078A Antagonists of mcp-1 function and methods of use thereof |
| 08/25/2004 | CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1523989A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 08/25/2004 | CN1522745A Traditional Chinese medicine extract with anti-inflammatory action and promoting blood circulation function, and its preparation method |
| 08/25/2004 | CN1522739A Bone fracture analgesic ointment |
| 08/25/2004 | CN1522735A Colitis therapeutic traditional Chinese medicine |
| 08/25/2004 | CN1522730A Rheumathritis capsule preparation method |
| 08/25/2004 | CN1522719A Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 08/25/2004 | CN1522707A Use of glede tea alcohol extract in preparation of antiphlogistic immune pharmaceutical |
| 08/25/2004 | CN1522702A Slow and control release aspirin capsule formulation and method for making same |
| 08/25/2004 | CN1163486C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 08/25/2004 | CN1163484C 4-Aroyl-Piperidin-CCR-3 receptor antagonist III |
| 08/25/2004 | CN1163477C Substituted beta-alanine |
| 08/25/2004 | CN1163466C Substituted oxobutyric acid derivative as matrix metalloprotease inhibitor |
| 08/25/2004 | CN1163231C Novel galanic formulation of meloxicam for oral administration |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780441 Composition of eleven herbals for treating cancer |
| 08/24/2004 | US6780427 Superoxide dismutase or other antioxidant are directly applied in combination with polymeric hydrogels at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | US6780398 Aqueous nasal formulation |
| 08/24/2004 | CA2313122C Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 08/24/2004 | CA2065051C Improved use of .beta.2 bronchodilator drugs |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069810A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069809A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069808A1 Acrylamide derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069797A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | WO2004069788A1 Carboxylic acid compounds |
| 08/19/2004 | WO2004069280A1 Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent |
| 08/19/2004 | WO2004069256A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 08/19/2004 | WO2004069240A2 Use in therapy of endocannabinoid-like compounds |
| 08/19/2004 | WO2004069149A2 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | WO2004006756A3 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 08/19/2004 | WO2003053364A3 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | US20040162435 Novel aliphatic compound, method of synthesis, and method of utilization |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162432 Substituted octahydrophenanthrene compounds and use thereof as NMDA antagonists |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162422 adenosine derivatives having an acetylene group in the 4' position, which are adenosine A1 agonists; treating ischaemic heart disease, peripheral vascular disease or stroke or patient suffering pain, a CNS disorder, sleep apnoea or emesis |
| 08/19/2004 | US20040162417 Nucleotide sequences coding metalloenzyme for use in detergents, therapeutic, cosmetics, leather processing, solubilizing or softening agents, foods, meat modifiers, feeds and oil and fat seperating agents |
| 08/19/2004 | US20040162388 Activated polyethylene glycol esters |
| 08/19/2004 | US20040162348 Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 08/19/2004 | US20040162324 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162304 Estrogen receptor modulators |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161478 Using plant extract as active material |
| 08/19/2004 | US20040161443 Vehicle |
| 08/19/2004 | US20040161405 Guanidinium transport reagents and conjugates |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515516A1 Carboxylic acid compounds |
| 08/19/2004 | CA2515147A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 08/19/2004 | CA2515102A1 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 08/19/2004 | CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | CA2514287A1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 08/19/2004 | CA2513109A1 Mercaptoimidazoles as ccr2 receptor antagonists |